[1]
F. Oliveira, J. Berretta, E. Chen, M. Smith, and P. Bertolucci, “Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease”, cm, vol. 47, no. 2, pp. 76-80, Jun. 2016.